[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019

December 2019 | 155 pages | ID: P6ADFECAF7CEN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019' provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Point-of-Care (POC) Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Point-of-Care (POC) Analyzers Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory
3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
3.5 Point-of-Care (POC) Analyzers - Ongoing Clinical Trials

4 POINT-OF-CARE (POC) ANALYZERS - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development

5 POINT-OF-CARE (POC) ANALYZERS COMPANIES AND PRODUCT OVERVIEW

5.1 Access Bio Inc Company Overview
  5.1.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Acrongenomics Inc (Inactive) Company Overview
  5.2.1 Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.3 AgPlus Diagnostics LTD Company Overview
  5.3.1 AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
5.4 Akers Biosciences Inc Company Overview
  5.4.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Akonni Biosystems Inc Company Overview
  5.5.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Alere Inc Company Overview
  5.6.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Analytical Diagnostic Solutions Inc Company Overview
  5.7.1 Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 ApoCell Inc Company Overview
  5.8.1 ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Aptatek BioSciences Inc Company Overview
  5.9.1 Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Atonomics A/S Company Overview
  5.10.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
5.11 BBB Technologies Inc Company Overview
  5.11.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Binghampton University Company Overview
  5.12.1 Binghampton University Pipeline Products & Ongoing Clinical Trials Overview
5.13 Bio-AMD Inc Company Overview
  5.13.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 BioMedomics Inc Company Overview
  5.14.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Biopico Systems Inc Company Overview
  5.15.1 Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Biosensia Ltd Company Overview
  5.16.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Boston University Company Overview
  5.17.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview
5.18 BreviTest Technologies LLC Company Overview
  5.18.1 BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.19 Brigham and Women's Hospital Company Overview
  5.19.1 Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.20 Calmark Sweden AB Company Overview
  5.20.1 Calmark Sweden AB Pipeline Products & Ongoing Clinical Trials Overview
5.21 Canon USA Inc Company Overview
  5.21.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 CardioGenics Inc Company Overview
  5.22.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Company Overview
  5.23.1 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Pipeline Products & Ongoing Clinical Trials Overview
5.24 Cepheid Company Overview
  5.24.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.25 ChipCare Corp Company Overview
  5.25.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
5.26 City, University of London Company Overview
  5.26.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview
5.27 Co-Diagnostics Inc Company Overview
  5.27.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Cornell University Company Overview
  5.28.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview
5.29 Cutting Edge Medical Devices Limited Company Overview
  5.29.1 Cutting Edge Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview
5.30 Diagnostics For All Inc Company Overview
  5.30.1 Diagnostics For All Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Duke University Company Overview
  5.31.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
5.32 EKF Diagnostics Holdings Plc Company Overview
  5.32.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Endeavor Sciences Inc Company Overview
  5.33.1 Endeavor Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 ExcitePCR Corp Company Overview
  5.34.1 ExcitePCR Corp Pipeline Products & Ongoing Clinical Trials Overview
5.35 Exosome Diagnostics Inc Company Overview
  5.35.1 Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.36 Fawkes Biotechnology LLC Company Overview
  5.36.1 Fawkes Biotechnology LLC Pipeline Products & Ongoing Clinical Trials Overview
5.37 First Light Diagnostics Inc Company Overview
  5.37.1 First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.38 Florida International University Company Overview
  5.38.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview
5.39 Future Diagnostics Solutions BV Company Overview
  5.39.1 Future Diagnostics Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
5.40 Giner Inc Company Overview
  5.40.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
5.41 GlucoSentient Inc Company Overview
  5.41.1 GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview
5.42 Indian Institute of Science Company Overview
  5.42.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
5.43 Indian Institute of Technology Chennai Company Overview
  5.43.1 Indian Institute of Technology Chennai Pipeline Products & Ongoing Clinical Trials Overview
5.44 Lucendi Inc Company Overview
  5.44.1 Lucendi Inc Pipeline Products & Ongoing Clinical Trials Overview
5.45 Masaryk University Company Overview
  5.45.1 Masaryk University Pipeline Products & Ongoing Clinical Trials Overview
5.46 Maxygen-mobile DNA tests Company Overview
  5.46.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview
5.47 mBio Diagnostics Inc Company Overview
  5.47.1 mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.48 McKesson Corp Company Overview
  5.48.1 McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview
5.49 Meridian Bioscience Inc Company Overview
  5.49.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.50 MML Ltd Company Overview
  5.50.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.51 Molecular Warehouse Ltd Company Overview
  5.51.1 Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.52 Nalia Systems Ltd Company Overview
  5.52.1 Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.53 Newcastle University Company Overview
  5.53.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
5.54 Nikkiso Co Ltd Company Overview
  5.54.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.55 Ohmx Corp Company Overview
  5.55.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
5.56 OncoGenesis Company Overview
  5.56.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview
5.57 Ontera Inc Company Overview
  5.57.1 Ontera Inc Pipeline Products & Ongoing Clinical Trials Overview
5.58 Pacific Nanoscience, Inc. Company Overview
  5.58.1 Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.59 POC Medical Systems Inc Company Overview
  5.59.1 POC Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.60 ProciseDx LLC Company Overview
  5.60.1 ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview
5.61 Quanterix Corp Company Overview
  5.61.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview
5.62 Qvella Corp Company Overview
  5.62.1 Qvella Corp Pipeline Products & Ongoing Clinical Trials Overview
5.63 Radisens Diagnostics Ltd Company Overview
  5.63.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.64 Raman Diagnostics Ltd (Inactive) Company Overview
  5.64.1 Raman Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.65 RMIT University Company Overview
  5.65.1 RMIT University Pipeline Products & Ongoing Clinical Trials Overview
5.66 SeLux Diagnostics Inc Company Overview
  5.66.1 SeLux Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.67 SenGenix Inc Company Overview
  5.67.1 SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.68 StemTek Therapeutics SL Company Overview
  5.68.1 StemTek Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview
5.69 Thermal Gradient Inc Company Overview
  5.69.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview
5.70 Trinity Biotech Plc Company Overview
  5.70.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
5.71 University of Calgary Company Overview
  5.71.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview
5.72 University of California Berkeley Company Overview
  5.72.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
5.73 University of Glasgow Company Overview
  5.73.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview
5.74 University of Illinois at Chicago Company Overview
  5.74.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.75 Wellstat Diagnostics LLC Company Overview
  5.75.1 Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

6 POINT-OF-CARE (POC) ANALYZERS- RECENT DEVELOPMENTS

6.1 Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance
6.2 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results
6.3 Oct 23, 2019: bioMerieux – Third-Quarter 2019 Business Review
6.4 Oct 22, 2019: bioMerieux – Third quarter 2019 business review
6.5 Oct 18, 2019: Calmark extends the time plan for CE-mark of the biomarkers LDH and Glucose - market launch as according to plan
6.6 Oct 18, 2019: McKesson’s Board of Directors appoints Maria Martinez as new independent Director
6.7 Oct 16, 2019: BioDirection announces move of corporate headquarters to Southborough, Massachusetts
6.8 Oct 08, 2019: Results for Calmark's initial biomarker, bilirubin, are within the expected range - project enters verification and validation phase to obtain CE mark
6.9 Oct 02, 2019: Selux Diagnostics beats key contract milestone, receives $11.4m in additional funding
6.10 Sep 25, 2019: Dr. Joanne Spadoro Joins First Light Diagnostics

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory
Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
Table 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials
Table 6: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
Table 7: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
Table 8: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: All-in-One Sensor - Product Status
Table 10: All-in-One Sensor - Product Description
Table 11: Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 12: BioLED Device - Diabetes Management - Product Status
Table 13: BioLED Device - Diabetes Management - Product Description
Table 14: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 15: AgPlus Diagnostic System - Product Status
Table 16: AgPlus Diagnostic System - Product Description
Table 17: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: minDNAnalyzer - Product Status
Table 19: minDNAnalyzer - Product Description
Table 20: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: TruDx 2000 Platform - Product Status
Table 22: TruDx 2000 Platform - Product Description
Table 23: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Clondiag HIV Molecular Device - Product Status
Table 25: Clondiag HIV Molecular Device - Product Description
Table 26: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: BiliNow - Product Status
Table 28: BiliNow - Product Description
Table 29: PKU Now - Product Status
Table 30: PKU Now - Product Description
Table 31: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: ApoStream System - Product Status
Table 33: ApoStream System - Product Description
Table 34: Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Point Of Care Diagnostic Device - Phenylketonuria - Product Status
Table 36: Point Of Care Diagnostic Device - Phenylketonuria - Product Description
Table 37: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Atolyzer PoC - Product Status
Table 39: Atolyzer PoC - Product Description
Table 40: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: markB - Product Status
Table 42: markB - Product Description
Table 43: Binghampton University Pipeline Products & Ongoing Clinical Trials Overview
Table 44: U-PAC - Product Status
Table 45: U-PAC - Product Description
Table 46: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Magnetic Immunoassay Detection System - Product Status
Table 48: Magnetic Immunoassay Detection System - Product Description
Table 49: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: TR-LFIA Diagnostic Analyzer - Product Status
Table 51: TR-LFIA Diagnostic Analyzer - Product Description
Table 52: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: MONITOR System - Product Status
Table 54: MONITOR System - Product Description
Table 55: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 56: RapiPlex System - Product Status
Table 57: RapiPlex System - Product Description
Table 58: Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Point-Of-Care Device - Allergen-Specific IgE - Product Status
Table 60: Point-Of-Care Device - Allergen-Specific IgE - Product Description

LIST OF FIGURES

Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory
Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
Figure 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials

COMPANIES MENTIONED

Access Bio Inc
AgPlus Diagnostics LTD
Akers Biosciences Inc
Akonni Biosystems Inc
Alere Inc
Analytical Diagnostic Solutions Inc
ApoCell Inc
Aptatek BioSciences Inc
Atonomics A/S
BBB Technologies Inc
Binghampton University
Bio-AMD Inc
BioMedomics Inc
Biopico Systems Inc
Biosensia Ltd
Boston University
BreviTest Technologies LLC
Brigham and Women's Hospital
Calmark Sweden AB
Canon USA Inc
CardioGenics Inc
Center for Innovation in Point-of-Care Technologies for HIV/AIDS
Cepheid
ChipCare Corp
City, University of London
Co-Diagnostics Inc
Cornell University
Cutting Edge Medical Devices Limited
Diagnostics For All Inc
Duke University
EKF Diagnostics Holdings Plc
Endeavor Sciences Inc
ExcitePCR Corp
Exosome Diagnostics Inc
Fawkes Biotechnology LLC
First Light Diagnostics Inc
Florida International University
Future Diagnostics Solutions BV
Giner Inc
GlucoSentient Inc
Indian Institute of Science
Indian Institute of Technology Chennai
Lucendi Inc
Masaryk University
Maxygen-mobile DNA tests
mBio Diagnostics Inc
McKesson Corp
Meridian Bioscience Inc
MML Ltd
Molecular Warehouse Ltd
Nalia Systems Ltd
Newcastle University
Nikkiso Co Ltd
Ohmx Corp
OncoGenesis
Ontera Inc
Pacific Nanoscience, Inc.
POC Medical Systems Inc
ProciseDx LLC
Quanterix Corp
Qvella Corp
Radisens Diagnostics Ltd
RMIT University
SeLux Diagnostics Inc
SenGenix Inc
StemTek Therapeutics SL
Thermal Gradient Inc
Trinity Biotech Plc
University of Calgary
University of California Berkeley
University of Glasgow
University of Illinois at Chicago
Wellstat Diagnostics LLC


More Publications